Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals
  • Primary Care

    Supporting every aspect of your clinical practice, including physical exam, diagnostic cardiology, vitals monitoring and vision screening

  • Hospital Care

    Advancing products and technologies designed to speed patient recovery and streamline clinical workflows

  • Surgical Care

    Delivering innovations that enable reduced operating times, faster patient recovery and improved outcomes

  • Kidney Care

    Pioneering care in hemodialysis (HD), peritoneal dialysis (PD) and digital health to support better outcomes for your patients

  • Nutritional Care

    Personalizing nutritional care designed to improve patients’ health in the hospital, the ICU and at home

  • Respiratory Care

    Helping your patients with respiratory therapies designed to simplify delivery and improve mobility

  • Our Products

    Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For nearly a century, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our 90-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Leadership

    Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere.

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We strive to create lasting value by empowering our patients, protecting our planet and championing our people and communities.

  • Diversity, Equity & Inclusion

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For nearly a century, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • General Healthcare

    Whether you are receiving care in the hospital, at your doctor’s office or at home, we are here to support every step of your journey.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain your nutritional status.

  • Kidney Care

    Kidney disease is an ongoing journey for you and your family. While every journey is unique, Baxter is committed to supporting access to care options to meet your medical and lifestyle needs.

  • Respiratory Care

    We are committed to helping you with innovative products that deliver effective, proven respiratory therapy in the hospital and at home.

Search Results

Business Content

Baxter Honored as a 2019 'Top Company for Executive Women' By the National Association for Female Executives

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE). This recognition highlights the company’s efforts to advance women in leadership and foster an inclusive and diverse culture.  

Financial Content

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on April 1, 2019, to shareholders of record as of March 1, 2019. The indicated annual dividend rate is $0.76 per share of common stock.

IIR Feature

Advancing Scientific Research to Improve Outcomes in the ICU

Investigator initiated research helps advance new innovations in critical care

Financial Content

Baxter to Present at the Barclays Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019.  Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 3:20 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through September 6, 2019.

Critical Care Content

Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU

NantHealth (NASDAQ: NH), a leader in connected care solutions, and Baxter International Inc. (NYSE:BAX), a global medical products company, today announced that a NantHealth digital health solution is now available to connect Baxter's Prismaflex system to a hospital electronic medical record (EMR).

Financial Content

Baxter to Present at the Raymond James 40th Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla. on Tuesday, March 5, 2019.  Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:25 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through April 2, 2019.

4Q & FY 2018 Financial Results Thumbnail

Baxter Reports 2018 Fourth-Quarter and Full-Year Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended Dec. 31, 2018, and provided its financial guidance for 2019.

Financial Content

Baxter to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Thursday, February 28, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:30 p.m. Eastern Time. The live webcast of Baxter’s presentation, can be accessed at www.baxter.com and will be available for replay through May 24, 2019.

Renal Care Content

Baxter Starts U.S. Clinical Trial for On-Demand Peritoneal Dialysis Solution System

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.S. clinical trial for the company’s on-demand peritoneal dialysis (PD) solution generation system. The innovative system is designed to improve the patient experience by making PD solutions in small batches in the patient’s home.

Baxter to Host Fourth Quarter 2018 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth quarter 2018 financial results on Thursday, January 31, 2019, at 7:30 a.m. Central Time. To access the call, dial (844) 886-1929 (domestic) or (225) 239-4663 (international).  Please dial into the call at least 10 minutes prior to the start for the operator to connect you. The Conference ID is 5056779.